KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area …

Dec 23, 2025 · Keytruda (pembrolizumab) is a PD-1 inhibitor treating 20+ cancer types, including melanoma, lung, head/neck, breast, gastric, colorectal, and kidney cancers. It is administered …

Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. …

Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.

KEYTRUDA, as a single agent, is indicated for the treatment of patients with metastatic NSCLC whose tumors express PD-L1 (TPS ≥1%) as determined by an FDA-approved test [see …

Healthcare professionals may find information on FDA-approved indications for KEYTRUDA® (pembrolizumab), along with related KEYNOTE trials. Explore the latest approvals here.

Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …